Evaluation of three preparations of etomidate.
Three formulations of etomidate were evaluated in unpremedicated patients undergoing minor gynaecological procedures. There was a high frequency of pain on injection (up to 50%) and excitatory phenomena (up to 95%) with all formulations. The frequency of excitatory phenomena was significantly greater than that after methohexitone. Recovery was rapid, but emetic sequelae were frequent and significantly more marked than after methohexitone.
D000771:Anesthesia, Intravenous / Q000379:methods; D002021:Buffers; D005045:Etomidate / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D011092:Polyethylene Glycols; D011409:Propylene Glycols; D012996:Solutions; D013997:Time Factors; D014867:Water
D002021:Buffers; D007093:Imidazoles; D011409:Propylene Glycols; D012996:Solutions; D014867:Water; D011092:Polyethylene Glycols; D005045:Etomidate